Green Thumb Industries (OTCMKTS:GTBIF) Releases Earnings Results, Beats Expectations By $0.03 EPS

Green Thumb Industries (OTCMKTS:GTBIF) announced its earnings results on Monday. The company reported $0.09 earnings per share for the quarter, beating the consensus estimate of $0.06 by $0.03, Zacks reports. The company had revenue of $280.15 million during the quarter, compared to the consensus estimate of $277.01 million. Green Thumb Industries had a net margin of 5.38% and a return on equity of 3.39%.

Green Thumb Industries Price Performance

GTBIF traded down $0.74 on Tuesday, reaching $10.07. 724,883 shares of the stock were exchanged, compared to its average volume of 510,888. Green Thumb Industries has a fifty-two week low of $6.42 and a fifty-two week high of $16.33. The firm has a market capitalization of $2.14 billion, a PE ratio of 41.96 and a beta of 1.41. The company’s 50-day moving average price is $11.61 and its 200 day moving average price is $12.57.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on GTBIF. Needham & Company LLC raised their price objective on Green Thumb Industries from $15.50 to $17.00 and gave the stock a “buy” rating in a research report on Thursday, May 9th. Wedbush boosted their price target on Green Thumb Industries from $15.00 to $16.00 and gave the stock an “outperform” rating in a research note on Friday, May 10th.

About Green Thumb Industries

Green Thumb Industries Inc manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands.